GADICKE ANSBERT

The estimated Net Worth of GADICKE ANSBERT is at least $540 Million dollars dollars as of 09/17/2021. GADICKE ANSBERT is the 10% Owner of Rigel Pharmaceuticals Inc. GADICKE ANSBERT owns over 1,833,597 shares of Rigel Pharmaceuticals Inc stock worth over $7 Million dollars . GADICKE ANSBERT is the Director of Verastem Inc. GADICKE ANSBERT owns over 2,033,333 shares of Verastem Inc stock worth over $5 Million dollars . GADICKE ANSBERT is the 10% Owner of Harpoon Therapeutics Inc. GADICKE ANSBERT owns over 8,422,847 shares of Harpoon Therapeutics Inc stock worth over $71 Million dollars . GADICKE ANSBERT is the Director, 10% Owner of TCR2 Therapeutics Inc. GADICKE ANSBERT owns over 7,421,847 shares of TCR2 Therapeutics Inc stock worth over $80 Million dollars . GADICKE ANSBERT is the 10% Owner of Repare Therapeutics Inc. GADICKE ANSBERT owns over 11,706,178 shares of Repare Therapeutics Inc stock worth over $353 Million dollars . GADICKE ANSBERT is the 10% Owner of Oncorus Inc. GADICKE ANSBERT owns over 2,377,025 shares of Oncorus Inc stock worth over $24 Million dollars .

GADICKE ANSBERT mailing address: THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116

Insider Roles

Name Transaction Date Position
Oncorus Inc 2020-10-06 10 percent owner
Dyne Therapeutics Inc 2020-09-21 10 percent owner
AlloVir Inc 2020-08-03 director, 10 percent owner
ITeos Therapeutics Inc 2020-07-28 director, 10 percent owner
Repare Therapeutics Inc 2020-06-23 10 percent owner
TCR2 Therapeutics Inc 2019-02-19 director, 10 percent owner
Harpoon Therapeutics Inc 2019-02-12 10 percent owner
Rhythm Pharmaceuticals Inc 2017-10-10 10 percent owner
Radius Health Inc 2017-02-17 director
Chiasma Inc 2016-06-09 director
Syndax Pharmaceuticals Inc 2016-03-08 10 percent owner
Avalo Therapeutics Inc 2015-10-20 10 percent owner
TriVascular Technologies Inc 2014-04-22 10 percent owner
Aratana Therapeutics Inc 2014-03-10 10 percent owner
Epizyme Inc 2014-02-10 10 percent owner
Histogen Inc 2013-07-30 10 percent owner
Pacira BioSciences Inc 2013-03-11 other: Former 10% Owner
Humanigen Inc 2013-02-05 10 percent owner
Verastem Inc 2012-03-06 director
EPIRUS Biopharmaceuticals Inc 2011-10-27 10 percent owner
Reshape Lifesciences Inc 2010-12-14 other: Former 10% Owner
Altimmune Inc 2010-11-03 10 percent owner
ARYx Therapeutics Inc 2010-09-30 10 percent owner
AVEO Pharmaceuticals Inc 2010-03-17 other: Former 10% Stockholder
Metabasis Therapeutics Inc 2010-01-27 10 percent owner
Poniard Pharmaceuticals Inc 2009-11-05 10 percent owner
Affymax Inc 2006-12-19 10 percent owner
Acorda Therapeutics Inc 2006-02-09 10 percent owner
Rigel Pharmaceuticals Inc 2004-09-13 other: Former 10% Owner
Cyclacel Pharmaceuticals Inc 2004-03-16 10 percent owner
EMBED
SAVE

GADICKE ANSBERT trading performance

Average Relative Return

1.62%

Average relative return per transaction

Outperforming Transactions

67%

2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .

GADICKE ANSBERT trading performance analysis

1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -5.16 -10.28 -10 1.62 8.82 -34.36
Relative Return to S&P 500(%) -7.93 -13.85 -14.73 -18.06 -22.66 -86.79

Gadicke Ansbert trading transactions

Ticker Company Price Insider Name Insider Position Date Buy/Sell Insider Trading Shares Shares Change Price Cost(000) Final Share Price Change Since Insider Trade (%) Dividend Yield % PE Ratio Market Cap ($M)
CGEM
Cullinan Oncology Inc
$27.46
GADICKE ANSBERT
Director, 10% Owner
2021-09-15 Sell
15,401
-0.19%
$29.17
$449.25
7,896,375
-5.86%
0
At Loss
1,181.27
CGEM
Cullinan Oncology Inc
$27.46
GADICKE ANSBERT
Director, 10% Owner
2021-09-13 Sell
26,468
-0.33%
$29.23
$773.66
7,911,776
-6.06%
0
At Loss
1,181.27
CGEM
Cullinan Oncology Inc
$27.46
GADICKE ANSBERT
Director, 10% Owner
2021-09-08 Sell
55,364
-0.69%
$29.20
$1,616.63
7,938,244
-5.96%
0
At Loss
1,181.27
CGEM
Cullinan Oncology Inc
$27.46
GADICKE ANSBERT
Director, 10% Owner
2021-09-02 Sell
27,669
-0.34%
$29.50
$816.24
7,993,608
-6.92%
0
At Loss
1,181.27
CGEM
Cullinan Oncology Inc
$27.46
GADICKE ANSBERT
Director, 10% Owner
2021-08-30 Sell
50,489
-0.63%
$29.24
$1,476.30
8,021,277
-6.09%
0
At Loss
1,181.27
CGEM
Cullinan Oncology Inc
$27.46
GADICKE ANSBERT
Director, 10% Owner
2021-08-25 Sell
120,592
-1.47%
$29.29
$3,532.14
8,071,766
-6.25%
0
At Loss
1,181.27
CGEM
Cullinan Oncology Inc
$27.46
GADICKE ANSBERT
Director, 10% Owner
2021-08-11 Sell
2,857
-0.03%
$29.05
$83.00
8,192,298
-5.47%
0
At Loss
1,181.27
RPTX
Repare Therapeutics Inc
$30.20
GADICKE ANSBERT
10% Owner
2021-07-12 Sell
62,079
-0.53%
$33.55
$2,082.75
11,706,178
-10%
0
At Loss
1,120.75
RPTX
Repare Therapeutics Inc
$30.20
GADICKE ANSBERT
10% Owner
2021-06-25 Sell
28,688
-0.36%
$33.51
$961.34
7,950,095
-9.89%
0
At Loss
1,120.75
RPTX
Repare Therapeutics Inc
$30.20
GADICKE ANSBERT
10% Owner
2021-06-23 Sell
42,798
-0.21%
$34.36
$1,470.54
20,007,717
-12.12%
0
At Loss
1,120.75
RPTX
Repare Therapeutics Inc
$30.20
GADICKE ANSBERT
10% Owner
2021-06-07 Sell
58,149
-0.23%
$32.01
$1,861.35
24,993,065
-5.67%
0
At Loss
1,120.75
RPTX
Repare Therapeutics Inc
$30.20
GADICKE ANSBERT
10% Owner
2021-05-27 Sell
38,559
-0.15%
$32.82
$1,265.51
25,529,336
-8%
0
At Loss
1,120.75
RPTX
Repare Therapeutics Inc
$30.20
GADICKE ANSBERT
10% Owner
2021-05-24 Sell
324,869
-2.46%
$34.75
$11,289.20
12,878,546
-13.11%
0
At Loss
1,120.75
RPTX
Repare Therapeutics Inc
$30.20
GADICKE ANSBERT
10% Owner
2021-05-20 Sell
46,904
-0.13%
$34.37
$1,612.09
37,025,937
-12.15%
0
At Loss
1,120.75
RPTX
Repare Therapeutics Inc
$30.20
GADICKE ANSBERT
10% Owner
2021-03-12 Sell
695,000
-6.91%
$28.18
$19,585.10
9,369,947
7.15%
0
At Loss
1,120.75
CGEM
Cullinan Oncology Inc
$27.46
GADICKE ANSBERT
Director, 10% Owner
2021-01-12 Buy
300,000
3.80%
$21
$6,300
8,195,155
30.76%
0
At Loss
1,181.27
ONCR
Oncorus Inc
$10.00
GADICKE ANSBERT
10% Owner
2020-10-06 Buy
325,000
15.84%
$15
$4,875
2,377,025
-33.33%
0
At Loss
255.17
RPTX
Repare Therapeutics Inc
$30.20
GADICKE ANSBERT
10% Owner
2020-06-23 Buy
500,000
10.22%
$20
$10,000
5,392,109
50.98%
0
At Loss
1,120.75
TCRR
TCR2 Therapeutics Inc
$10.99
GADICKE ANSBERT
Director, 10% Owner
2019-02-19 Buy
1,373,333
22.71%
$15
$20,600
7,421,847
-26.73%
0
At Loss
411.57
HARP
Harpoon Therapeutics Inc
$8.52
GADICKE ANSBERT
10% Owner
2019-02-12 Sell
1,971
-0.02%
$14
$27.59
8,422,847
-39.14%
0
At Loss
275.08
HARP
Harpoon Therapeutics Inc
$8.52
GADICKE ANSBERT
10% Owner
2019-02-12 Buy
500,000
6.31%
$14
$7,000
8,422,847
-39.14%
0
At Loss
275.08
PETX
Aratana Therapeutics Inc
$4.92
GADICKE ANSBERT
10% Owner
2014-03-07 Sell
26,713
-41.85%
$20.16
$538.53
37,117
-75.60%
0
At Loss
241.09
VSTM
Verastem Inc
$2.65
GADICKE ANSBERT
Director
2012-02-01 Buy
100,000
5.17%
$10
$1,000
2,033,333
-73.50%
0
At Loss
477.20
RIGL
Rigel Pharmaceuticals Inc
$3.92
GADICKE ANSBERT
10% Owner
2004-07-02 Sell
2,463
-0.13%
$14.59
$35.94
1,833,597
-73.13%
0
At Loss
664.61
Total 24
  • 1

GADICKE ANSBERT personal network

Name Position Linked company